HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Immunoglobulin allotypes are not associated with HLA-antigens, autoantibodies and clinical symptoms in systemic lupus erythematosus. Members of the SLE Study Group.

Abstract
Immunoglobulin heavy chain (G1m, G2m, G3m, A2m) and kappa light chain (Km) allotype and phenotype frequencies of 323 central European Caucasian patients with systemic lupus erythematosus (SLE) were examined and correlated with various genetic, serologic and clinical markers of SLE. No significant associations were found between immunoglobulin allotypes or phenotypes and all 20 parameters tested (nephritis, vasculitis, arthralgias, photosensitivity, discoid lesions, central nervous system disease, Raynaud's phenomenon, sex, anti-Ro, anti-La, anti-nRNP, HLA-DR1-DR7, HLA phenotypes B8-DR3, B7-DR2). It could therefore be assumed that Gm, A2m and Km allotypes were not associated with HLA-antigens and had no influence on the serologic and clinical expression of SLE.
AuthorsK Hartung, R Coldewey, E Röther, K Pirner, C Specker, D Schendel, W Stangel, S Stannat-Kiessling, G G de Lange
JournalRheumatology international (Rheumatol Int) Vol. 11 Issue 4-5 Pg. 179-82 ( 1991) ISSN: 0172-8172 [Print] Germany
PMID1784886 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Autoantibodies
  • Genetic Markers
  • HLA Antigens
  • Immunoglobulin Allotypes
  • Immunoglobulin Heavy Chains
  • Immunoglobulin kappa-Chains
Topics
  • Autoantibodies (immunology)
  • Europe
  • Genetic Markers
  • HLA Antigens (immunology)
  • Humans
  • Immunoglobulin Allotypes (genetics, immunology)
  • Immunoglobulin Heavy Chains (immunology)
  • Immunoglobulin kappa-Chains (immunology)
  • Lupus Erythematosus, Systemic (epidemiology, genetics, immunology)
  • Phenotype
  • White People (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: